UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl

The Journal of nuclear medicine (1978), 2016-02, Vol.57 (2), p.315-320

2016

Volltextzugriff (PDF)

In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO-B pet radioligand

Synapse (New York, N.Y.), 2012-04, Vol.66 (4), p.323-330

2012

Volltextzugriff (PDF)

Highly Efficient Synthesis of Linear Pyrrole Oligomers by Twofold Heck Reactions

Chemistry : a European journal, 2001-01, Vol.7 (2), p.368-373

2001

Volltextzugriff (PDF)

Development of a fast robust derivatization method of an extremely polar PET radiopharmaceutical: a critical aspect for starting a clinical trial

Tetrahedron letters, 2013-05, Vol.54 (21), p.2583-2586

2013

Volltextzugriff (PDF)

Radiofluorinated Derivatives of 2‑(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer

Journal of medicinal chemistry, 2012-11, Vol.55 (22), p.9510-9520

2012

Volltextzugriff (PDF)

Synthesis of Three Novel Fluorine-18 Labeled Analogues of l-Deprenyl for Positron Emission Tomography (PET) studies of Monoamine Oxidase B (MAO-B)

Journal of medicinal chemistry, 2011-10, Vol.54 (20), p.7023-7029

2011

Volltextzugriff (PDF)

Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

European journal of nuclear medicine and molecular imaging, 2014, Vol.41 (1), p.89-101

2014

Volltextzugriff (PDF)

Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

European journal of nuclear medicine and molecular imaging, 2014-01, Vol.41 (1), p.89

2014

Volltextzugriff (PDF)

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, ^sup 18^F-Labeled Deuterated Fluorodeprenyl

The Journal of nuclear medicine (1978), 2016-02, Vol.57 (2), p.315

2016

Volltextzugriff (PDF)

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18 F-Labeled Deuterated Fluorodeprenyl

Journal of Nuclear Medicine, 2016-02, Vol.57 (2), p.315-320

2016

Volltextzugriff (PDF)

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, sigma up 18 Theta -Labeled Deuterated Fluorodeprenyl

The Journal of nuclear medicine (1978), 2016-02, Vol.57 (2), p.315-315

2016

Volltextzugriff (PDF)

Preclinical evaluation of BAY 1075553, a novel super(18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

European journal of nuclear medicine and molecular imaging, 2014-01, Vol.41 (1), p.89-101

2014

Volltextzugriff (PDF)

Preclinical evaluation of BAY 1075553, a novel ^sup 18^F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

European journal of nuclear medicine and molecular imaging, 2014-01, Vol.41 (1), p.89

2014

Volltextzugriff (PDF)

Discovery and Synthesis of (S)-3-[2-(3,4-Dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ETA/ETB Receptor Antagonist

Journal of medicinal chemistry, 1999-08, Vol.42 (16), p.3026-3032

1999

Volltextzugriff (PDF)

Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist

Journal of medicinal chemistry, 1999-08, Vol.42 (16), p.3026-3032

1999

Volltextzugriff (PDF)

An enantiospecific cobaloxime π-cation initiated carbocyclisation

Tetrahedron letters, 1998-04, Vol.39 (14), p.2027-2028

1998

Volltextzugriff (PDF)

Synthesis of N-Protected 2-Hydroxymethylpyrroles and Transformation into Acyclic Oligomers

Synthesis (Stuttgart), 1996-07, Vol.1996 (7), p.851-857

1996

Volltextzugriff (PDF)

Kinase Data Mining: Dealing with the Information (Over-)Flow

ChemBioChem, 2005-03, Vol.6 (3), p.567-570

2005

Volltextzugriff (PDF)

Discovery and Synthesis of ( S )-3-[2-(3,4-Dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ET A /ET B Receptor Antagonist

Journal of medicinal chemistry, 1999-08, Vol.42 (16), p.3026-3032

1999

Volltextzugriff (PDF)

ChemInform Abstract: Highly Efficient Synthesis of Linear Pyrrole Oligomers by Twofold Heck Reactions

ChemInform, 2002-03, Vol.33 (10), p.no-no

2002

Volltextzugriff (PDF)

ChemInform Abstract: Discovery and Synthesis of (S)‐3‐[2‐(3,4‐Dimethoxyphenyl)ethoxy] ‐2‐(4,6‐dimethylpyrimidin‐2‐yloxy)‐3,3‐diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ET A /ET B Receptor Antagonist

ChemInform, 1999-12, Vol.30 (51)

1999

Volltextzugriff (PDF)

ChemInform Abstract: Discovery and Synthesis of (S)-3-[2-(3,4-Dimethoxyphenyl)ethoxy] -2-(4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ETA/ETB Receptor Antagonist

ChemInform, 1999-12, Vol.30 (51), p.no-no

1999

Volltextzugriff (PDF)

Berufsbildung für eine nachhaltige Entwicklung: Themenschwerpunkt

Berufsbildung, 2013, Vol.67 (141), p.2-33

2013

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Animals
(7)
Humans
(5)
Life Sciences & Biomedicine
(5)
Male
(5)
Chemistry
(4)
Physical Sciences
(4)
Stereoisomerism
(4)
Chemistry, Medicinal
(3)
Chemistry, Organic
(3)
Fluorine Radioisotopes
(3)
Medicin Och Hälsovetenskap
(3)
Mice
(3)
Pharmacology & Pharmacy
(3)
Radiopharmaceuticals - Pharmacokinetics
(3)
Antigens
(2)
Autoradiography
(2)
Blood Proteins - Metabolism
(2)
Brain - Diagnostic Imaging
(2)
Female
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl

In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO-B pet radioligand

Highly Efficient Synthesis of Linear Pyrrole Oligomers by Twofold Heck Reactions

Development of a fast robust derivatization method of an extremely polar PET radiopharmaceutical: a critical aspect for starting a clinical trial

Radiofluorinated Derivatives of 2‑(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer

Synthesis of Three Novel Fluorine-18 Labeled Analogues of l-Deprenyl for Positron Emission Tomography (PET) studies of Monoamine Oxidase B (MAO-B)

Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, ^sup 18^F-Labeled Deuterated Fluorodeprenyl

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18 F-Labeled Deuterated Fluorodeprenyl

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, sigma up 18 Theta -Labeled Deuterated Fluorodeprenyl

Preclinical evaluation of BAY 1075553, a novel super(18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

Preclinical evaluation of BAY 1075553, a novel ^sup 18^F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

Discovery and Synthesis of (S)-3-[2-(3,4-Dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ETA/ETB Receptor Antagonist

Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist

An enantiospecific cobaloxime π-cation initiated carbocyclisation

Synthesis of N-Protected 2-Hydroxymethylpyrroles and Transformation into Acyclic Oligomers

Kinase Data Mining: Dealing with the Information (Over-)Flow

Discovery and Synthesis of ( S )-3-[2-(3,4-Dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ET A /ET B Receptor Antagonist

ChemInform Abstract: Highly Efficient Synthesis of Linear Pyrrole Oligomers by Twofold Heck Reactions

ChemInform Abstract: Discovery and Synthesis of (S)‐3‐[2‐(3,4‐Dimethoxyphenyl)ethoxy] ‐2‐(4,6‐dimethylpyrimidin‐2‐yloxy)‐3,3‐diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ET A /ET B Receptor Antagonist

ChemInform Abstract: Discovery and Synthesis of (S)-3-[2-(3,4-Dimethoxyphenyl)ethoxy] -2-(4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ETA/ETB Receptor Antagonist

Berufsbildung für eine nachhaltige Entwicklung: Themenschwerpunkt

Suchergebnisse filtern